Paul Wyman

2.4k total citations
43 papers, 1.9k citations indexed

About

Paul Wyman is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Paul Wyman has authored 43 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Organic Chemistry, 20 papers in Molecular Biology and 12 papers in Cellular and Molecular Neuroscience. Recurrent topics in Paul Wyman's work include Receptor Mechanisms and Signaling (11 papers), Neurotransmitter Receptor Influence on Behavior (8 papers) and Advanced Polymer Synthesis and Characterization (6 papers). Paul Wyman is often cited by papers focused on Receptor Mechanisms and Signaling (11 papers), Neurotransmitter Receptor Influence on Behavior (8 papers) and Advanced Polymer Synthesis and Characterization (6 papers). Paul Wyman collaborates with scholars based in United Kingdom, United States and Netherlands. Paul Wyman's co-authors include Nicholas H. Williams, Elizabeth R. Jones, Richard Wolfenden, Mona Semsarilar, Gottfried K. Schroeder, Steven P. Armes, Graham J. Riley, Neil R. Cameron, Scott D. Kimmins and Barry S. Orlek and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Biomaterials.

In The Last Decade

Paul Wyman

41 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul Wyman United Kingdom	23	872	644	319	303	221	43	1.9k
Giuseppe Trapani Italy	38	847 1.0×	1.2k 1.8×	468 1.5×	292 1.0×	56 0.3×	111	3.8k
Veena Belgamwar India	28	196 0.2×	636 1.0×	97 0.3×	121 0.4×	60 0.3×	60	2.4k
Krishna K. Sharma India	33	808 0.9×	769 1.2×	315 1.0×	923 3.0×	18 0.1×	101	3.2k
Takuji Yamaguchi Japan	23	377 0.4×	531 0.8×	147 0.5×	117 0.4×	32 0.1×	106	1.9k
Massimo Franco Italy	35	683 0.8×	862 1.3×	272 0.9×	271 0.9×	12 0.1×	104	2.9k
Ian S. Blagbrough United Kingdom	31	697 0.8×	2.1k 3.3×	276 0.9×	188 0.6×	14 0.1×	150	3.4k
Naresh Kumar United States	30	1.1k 1.2×	955 1.5×	164 0.5×	132 0.4×	18 0.1×	64	3.6k
Prashant Deshmukh India	20	669 0.8×	551 0.9×	53 0.2×	297 1.0×	10 0.0×	39	1.6k
Lóránd Kiss Hungary	21	464 0.5×	415 0.6×	48 0.2×	87 0.3×	21 0.1×	62	1.7k
Janice Limson South Africa	23	198 0.2×	617 1.0×	112 0.4×	205 0.7×	30 0.1×	65	2.2k

Countries citing papers authored by Paul Wyman

Since Specialization

Citations

This map shows the geographic impact of Paul Wyman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Wyman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Wyman more than expected).

Fields of papers citing papers by Paul Wyman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Wyman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Wyman. The network helps show where Paul Wyman may publish in the future.

Co-authorship network of co-authors of Paul Wyman

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Wyman. A scholar is included among the top collaborators of Paul Wyman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Wyman. Paul Wyman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gonzato, Carlo, Mona Semsarilar, Elizabeth R. Jones, et al.. (2014). Rational Synthesis of Low-Polydispersity Block Copolymer Vesicles in Concentrated Solution via Polymerization-Induced Self-Assembly. Journal of the American Chemical Society. 136(31). 11100–11106. 122 indexed citations

Porter, Roderick A., Amanda Johns, D. Nash, et al.. (2011). Acylglycinamides as inhibitors of glycine transporter type 1. Bioorganic & Medicinal Chemistry Letters. 21(20). 6176–6179. 1 indexed citations

Forbes, Ian T., Steve P. Watson, Graeme I. Stevenson, et al.. (2010). The discovery of a series of N-substituted 3-(4-piperidinyl)-1,3-benzoxazolinones and oxindoles as highly brain penetrant, selective muscarinic M1 agonists. Bioorganic & Medicinal Chemistry Letters. 20(18). 5434–5438. 16 indexed citations

Ward, Simon E., Peter Eddershaw, Laurie Gordon, et al.. (2008). Studies on a series of potent, orally bioavailable, 5-HT1 receptor ligands—Part II. Bioorganic & Medicinal Chemistry Letters. 19(2). 428–432. 7 indexed citations

Smith, Paul W., Paul Wyman, Peter J. Lovell, et al.. (2008). New quinoline NK3 receptor antagonists with CNS activity. Bioorganic & Medicinal Chemistry Letters. 19(3). 837–840. 45 indexed citations

Rimmer, Stephen, Claire Johnson, Paul Wyman, et al.. (2007). Epithelialization of hydrogels achieved by amine functionalization and co-culture with stromal cells. Biomaterials. 28(35). 5319–5331. 47 indexed citations

Scott, Claire M., Christopher J. Langmead, Paul Wyman, et al.. (2006). SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2′methyl-4′-(5-methyl-1,2,3-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): A novel, potent and selective 5-HT1B receptor antagonist. Neuropharmacology. 50(8). 984–990. 5 indexed citations

Wyman, Paul, Mervyn Thompson, Paul W. Smith, et al.. (2005). Identification of a potent and selective 5-HT1B receptor antagonist. Bioorganic & Medicinal Chemistry Letters. 15(21). 4708–4712. 2 indexed citations

Rami, Harshad K., Mervyn Thompson, Paul Wyman, et al.. (2004). Discovery of small molecule antagonists of TRPV1. Bioorganic & Medicinal Chemistry Letters. 14(14). 3631–3634. 50 indexed citations

10.

Gunthorpe, Martin J., Harshad K. Rami, Jeffrey C. Jerman, et al.. (2003). Identification and characterisation of SB-366791, a potent and selective vanilloid receptor (VR1/TRPV1) antagonist. Neuropharmacology. 46(1). 133–149. 220 indexed citations

11.

King, Frank D., et al.. (2003). The Discovery and Development of 5-HT-terminal Autoreceptor Antagonists. Progress in medicinal chemistry. 41. 129–165. 2 indexed citations

12.

Watson, Jeannette M., C. Roberts, Claire M. Scott, et al.. (2001). SB‐272183, a selective 5‐HT_1A, 5‐HT_1B and 5‐HT_1D receptor antagonist in native tissue. British Journal of Pharmacology. 133(6). 797–806. 15 indexed citations

13.

Roberts, C., Jim J. Hagan, Nigel Austin, et al.. (2000). The effect of SB-236057-A, a selective 5-HT 1B receptor inverse agonist, on in vivo extracellular 5-HT levels in the freely-moving guinea-pig. Naunyn-Schmiedeberg s Archives of Pharmacology. 362(2). 177–183. 22 indexed citations

14.

Middlemiss, Derek N., Manfred Göthert, Eberhard Schlicker, et al.. (1999). SB-236057, a selective 5-HT1B receptor inverse agonist, blocks the 5-HT human terminal autoreceptor. European Journal of Pharmacology. 375(1-3). 359–365. 31 indexed citations

15.

Bromidge, Steven M., Steven Dabbs, David T. Davies, et al.. (1998). Novel and Selective 5-HT_2C/2B Receptor Antagonists as Potential Anxiolytic Agents: Synthesis, Quantitative Structure−Activity Relationships, and Molecular Modeling of Substituted 1-(3-Pyridylcarbamoyl)indolines. Journal of Medicinal Chemistry. 41(10). 1598–1612. 53 indexed citations

16.

Wyman, Paul, Laramie M. Gaster, Frank D. King, et al.. (1996). Azabicyclic indole esters as potent 5-HT4 receptor antagonists. Bioorganic & Medicinal Chemistry. 4(2). 255–261. 8 indexed citations

17.

Gaster, Laramie M., Graham F. Joiner, Paul Wyman, et al.. (1995). N-[(1-Butyl-4-piperidinyl)methyl]-3,4- dihydro-2H-[1,3]oxazino[3,2-a]indole- 10-carboxamide hydrochloride: the first potent and selective 5-HT4 receptor antagonist amide with oral activity.. Journal of Medicinal Chemistry. 38(24). 4760–4763. 34 indexed citations

18.

Gaster, Laramie M., A.J. Jennings, Graham F. Joiner, et al.. (1993). (1-Butyl-4-piperidinyl)methyl 8-amino-7-chloro-1,4-benzodioxane-5-carboxylate hydrochloride: a highly potent and selective 5-HT4 receptor antagonist derived from metoclopramide. Journal of Medicinal Chemistry. 36(25). 4121–4123. 30 indexed citations

19.

Jenkins, S. M., Harry J. Wadsworth, Steven M. Bromidge, et al.. (1992). Substituent variation in azabicyclic triazole- and tetrazole-based muscarinic receptor ligands. Journal of Medicinal Chemistry. 35(13). 2392–2406. 61 indexed citations

20.

Orlek, Barry S., Frank E. Blaney, Frank Brown, et al.. (1991). Comparison of azabicyclic esters and oxadiazoles as ligands for the muscarinic receptor. Journal of Medicinal Chemistry. 34(9). 2726–2735. 171 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact